Development of a Face Valid Executive Functioning Task (MedTask)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2009 by Washington University School of Medicine.
Recruitment status was  Active, not recruiting
Sponsor:
Collaborator:
American Parkinson's Disease Association, Inc
Information provided by:
Washington University School of Medicine
ClinicalTrials.gov Identifier:
NCT00918112
First received: June 8, 2009
Last updated: June 9, 2009
Last verified: June 2009
  Purpose

The purpose of this study is to develop a task to measure executive thinking skills that can be performed in a laboratory setting, but has clear parallels to the thinking demands of real life situations, and can be administered to patients such as those with Parkinson's who have difficulty moving.


Condition
Parkinson's Disease

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: Development of a Face Valid Executive Functioning Task

Resource links provided by NLM:


Further study details as provided by Washington University School of Medicine:

Enrollment: 20
Study Start Date: September 2004
Estimated Study Completion Date: November 2013
Groups/Cohorts
Parkinson's Disease
Meets criteria for definite Parkinson's Disease
Healthy Controls
- Must be in good health

  Eligibility

Ages Eligible for Study:   20 Years to 70 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Recruit participants through Volunteer for Health, word of mouth, and from a clinical population at the Washington University in St Louis School of Medicine's Neurological Clinical Research Unit (NCRU).

Criteria

Brief Inclusion Criteria Parkinson's Disease (PD) group:

  • Must have definite PD
  • have clear benefit from levodopa

Brief Exclusion Criteria PD Group and Control:

  • Hx of stroke
  • Head injury
  • Visual loss
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00918112

Locations
United States, Missouri
Washington University School of Medicine
St. Louis, Missouri, United States, 63110
Sponsors and Collaborators
Washington University School of Medicine
American Parkinson's Disease Association, Inc
Investigators
Principal Investigator: Tamara G Hershey, PhD. Washington University School of Medicine
  More Information

Additional Information:
No publications provided

Responsible Party: Hershey, Tamara Ph.D., Washington Uinversity School of Medicine
ClinicalTrials.gov Identifier: NCT00918112     History of Changes
Other Study ID Numbers: 04-0841
Study First Received: June 8, 2009
Last Updated: June 9, 2009
Health Authority: United States: Institutional Review Board

Keywords provided by Washington University School of Medicine:
Parkinson's Disease

Additional relevant MeSH terms:
Parkinson Disease
Parkinsonian Disorders
Basal Ganglia Diseases
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Movement Disorders
Neurodegenerative Diseases

ClinicalTrials.gov processed this record on September 16, 2014